FLORHAM PARK, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity,” “the Company”), a biotechnology company developing placental-derived allogeneic cell therapies and ...
FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial ...
ZURICH, Jan. 12, 2026 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the ...
Understanding and controlling how cancer cells transition between different states remains a critical challenge in tumor biology. In a recent publication in Advanced Materials, a team from the Leibniz ...
Advanced biomaterials for wound healing encompass a diverse array of engineered constructs designed to interact favourably with the physiological environment, modulate key stages of repair and deliver ...
The light-regulated living biomaterial. Light stimulates the display of RGD by E. coli bacteria, enabling interaction with mammalian cells. (Courtesy: Advanced Science 10.1002/advs.201800383/CC BY 4.0 ...
The biomaterials market is anticipated to expand at a rapid pace due to aging global population and the escalating prevalence of chronic diseases. The biomaterials market is experiencing robust growth ...
Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human placental-derived biomaterials at ICBST23, the International Conference on Biomaterials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results